Objectives: To explore a contradiction between evidence suggesting community treatment order (CTO) ineffectiveness and clinical experience.
I n community psychiatry, treatment adherence exists on a continuum, from encouragement in planning for the person to reach their goals, through to a legally sanctioned, enforceable process by which people with a serious mental illness are required to accept psychiatric treatment whilst living outside hospital. The latter arose from deinstitutionalisation including rare but tragic events. 1 Whilst initially attracting civil libertarian support, treatment was in a less restrictive setting, concerns developed regarding the deprivation of liberties that might occur when treatment is imposed against the wishes of another. 2 A decision with two effects, one good and one bad, is permissible under five conditions: (1) the decision itself is good; (2) only the good effect is intended; (3) the good effect is not via the bad effect; (4) alternative attempts have been unsuccessful; and (5) there was a risk to not acting. 3 Community treatment orders (CTOs) should be able to demonstrate clinical effectiveness and if unable, they also become ethically unjustifiable.
The consistency in the conclusion that three randomised controlled trials (RCTs) and subsequent meta-analyses have shown no benefit for CTOs across different jurisdictions, different mental health services and different legislative practices is compelling. [4] [5] [6] [7] [8] [9] [10] [11] However this result stood in contrast with personal clinical experience and given the place of evidence-based medicine (EBM), required consideration.
The evidence base for and against CTOs
Field research is difficult and for CTOs, difficult conceptually, ethically, legally and logistically. 2 For these reasons there have only been three RCTs. The first study in New York, USA randomised 142 outpatients to either a court ordered CTO or voluntary status, both groups receiving greater than standard case management and followed up for 11 months. 4 The second study from North Carolina, USA randomised 264 patients from four inpatient facilities to CTO or voluntary status, who received case management and were followed up for 12 months. 5 In the third, Oxford CTO Evaluation Trial (OCTET), 336 clinician randomised patients from 32 hospitals were either on the newly introduced CTO or on Section 17 leave, received multidisciplinary case management and were followed up for 12 months. 6 For these 742 patients, no differences in readmission, service use, social functioning, mental state, homelessness, satisfaction with services or perceived coercion were found. The literature appears to suggest that CTOs are ineffective.
The author has worked for 30+ years in New Zealand (NZ), rural Australia and the United Kingdom prior to CTO legislation. Part of the difference in clinical practice has been the decisiveness with which systems are able to respond. Everyday clinical practice has included sitting with exasperated families compared with people on CTOs being swiftly returned to compulsory treatment, recover and remain well. Tasked in the public sector to focus on significant and enduring mental illnesses, 11% of the 200 people currently being seen by the author were on CTOs, a rate of 48 per 100,000. (As there are conceptual differences between CTOs, international comparisons are difficult. 2 However a 3-fold regional variation in NZ ranging from 47 to 164 per 100,000 was reported in 2015). 12 All patients had histories of violence and/or neglect, were non-consenting and had multiple hospitalisations; 91% had schizophrenia. Of those who had been previously discharged from CTOs, 77% had relapsed with 23% not being offered discharge due to risk or an inability to provide consent, a position upheld by the Mental Health Review Tribunal process. Interestingly only five patients had CTOs initiated by the author in the past 5 years, all others having been inherited. Clinical experience suggests CTO effectiveness. Both statements cannot be correct.
The clinician's illusion refers to the observation that the population within which a person works frames their experience. Recovered patients do not return, whereas relapsed patients do, creating mistaken but infective nihilism. 13 The corollary arises when a particular intervention, CTOs, appears to have been useful but the effect was due to another phenomenon including improvement over time, revised treatment planning, additional resources or closer monitoring.
Bias is universal however and in the literature, there were subtle omissions. Despite considerable confusion as to who was in which group with mechanisms to enforce court orders lacking, the first RCT actually showed that the median number of days hospitalised for the CTO group was 43 compared with 101 for the control group. The study was insufficiently powered to exclude this difference having occurred by chance. The second study also showed benefits. When combined with sustained and intensive follow up, there was a significant reduction in hospital readmissions, fewer days in hospital, with patients less likely to be violent and less likely to be victims of crime. However, the major concern related to the representativeness of the sample and therefore the applicability to my practice. In the New York and North Carolina studies, patients with a history of violence were excluded. In the OCTET study, all participants were consenting and although subject to different sections of the Mental Health Act, both groups were subject to a legal mandate, quaintly acknowledged as legal equipoise. Further, though duration under the Act differed, the use of the median rather than the mean likely misrepresented the actual difference. 14 Whilst the conclusion that three RCTs show weak evidence is plausible, an alternative summary of the same data set can be made. That a reinterpretation is possible begs the question as to which methodology is best suited for answering which question.
Clinicians follow patients across time. A 5 year, before and after Scottish study of 1558 people on CTOs found that the number of hospital bed days fell from 66 to 39 per annum per patient. 15 A Canadian review showed a reduction in hospitalisation, an increase in outpatient participation and an improvement in housing. 16 For those rehospitalised in the District of Columbia, seclusion and restraint was significantly reduced in the 2 years following outpatient commitment. 17 Although the Victorian studies are cited as demonstrating increasing admissions, this too is a misrepresentation of that 9 year study involving 16,216 CTOs. Readmissions increased, but only for individuals following their first admission. For subsequent episodes, the risk of being admitted was reduced as was mortality. 18, 19 Concerns regarding coercion including restrictions to personal liberty may also have been overstated. In one NZ study, only 3 of 42 patients were totally opposed to CTOs, the majority of patients acknowledging CTO usefulness as a step towards community stability. 20 Valid criticisms of these methodologies have also been articulated in multiple reviews. 2, [6] [7] [8] [9] [10] [11] How then does the clinician proceed?
The clinical usefulness of CTOsa personal view "Above all, humility, respect for the people one is trying to help, appreciation of the enormous difficulty of providing meaningful assistance and recognition of the possibility that stereotypes and biases are operating in one's clinical practise". 21 Appelbaum asks how do we care for people who experience recurrent illnesses that may require repeat hospitalisation, who are treatment-responsive and yet resistant to participating in that treatment. 22 The task is further complicated by the subset of people who lack insight as a biological concomitant of the disease, 23 the observation that delays to treatment and recurrent relapses are associated with poorer outcomes 24 and by service-related and societal factors. 25 There are ethical tensions associated with CTOs. 26 JS Mill presents the basis for autonomy, society interfering with an individual's freedom at its peril. However, Mill, aware of balancing individuality and society's concern for that individual, also introduced a number of exclusion criteria including those that are mentally ill. 27 Clinicians who are interested in the good of their patients have to bear the tension of difficult decisions.
Further, intervention in the best interests of another need not be associated with a loss of liberty or with coercion. 28 EBM is the conscientious, explicit and judicious use of current research in making decisions about the care of individual patients. Although overlooked, it also includes the considered integration of individual clinical expertise. Given that the CTO literature can be interpreted differently by the lens through which it is viewed, and therefore the proposition that the evidence base for CTOs is weak is itself unsafe, a case for CTOs may be made.
The exercise of auditing clinical practice in response to an apparent finding has been useful. Conversing with the person and their family around historical and therefore likely future risk confirms the continuation in the inherited group. A community reasonably expects this. For the person not immediately at risk, but for whom the CTO is employed to stabilise and enable personal goals to be reached, a conversation can occur. Given the best efforts of both parties, how many relapses will each accept before together we agree on trialling a CTO? If nothing changes, nothing can change.
Conclusions
The headline that three RCTs and subsequent reviews fail to show a difference has been accepted and disseminated. However, this may be the academics' illusion. An awareness of the power differential between the person on a CTO and the medical and legal professions and the relative ease with which a person may be held under a CTO is important in order to avoid what JS Mill referred to as the deep slumber of the decided opinion. However, there is both an evidential and ethical justification for CTOs.
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